MetaCap

Damora Therapeutics (DMRA) News

NASDAQ: DMRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

23.22-1.08 (-4.44%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

DMRA news summary

We found 2 recent headlines mentioning Damora Therapeutics (DMRA): 0 in the past week and 2 in the past 30 days, most often from Seeking Alpha, GlobeNewswire. For price context, DMRA is down 4.44% at $23.22. The most recent story, "Damora Therapeutics GAAP EPS of -$0.40 beats by $0.07", was published by Seeking Alpha on Nov 4, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Damora Therapeutics headlines

Compare DMRA